GNCAQ
Genocea Biosciences Inc

8,469
Mkt Cap
$59.00
Volume
9,250.00
52W High
$0.0001
52W Low
$0.00
Price
$0.00
GNCAQ Fundamentals
Prev Close
$0.0001
50D MA
$0.00
Beta
0.00
Avg. Volume
689.45
Loading...
Loading...

About

Genocea Biosciences, Inc. engages in the development and commercialization of cancer immunotherapies. The firm uses its proprietary technology platform, ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses. Its product candidates include GEN-011, an investigational adoptive T cell therapy and GEN-009, a neoantigen cancer vaccine. The company was founded by Robert Paull and Kevin J. Bitterman on August 16, 2006 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Genocea Biosciences Inc?
What is the 52-week high for Genocea Biosciences Inc?
What was Genocea Biosciences Inc stock price yesterday?

Latest GNCAQ News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.